First Time Loading...

Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 15.3 USD 3.94% Market Closed
Updated: May 5, 2024
Section:
 

Relative Value

The Relative Value of one NEO stock under the Base Case scenario is 20.77 USD. Compared to the current market price of 15.3 USD, Neogenomics Inc is Undervalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NEO Relative Value
Base Case
20.77 USD
Undervaluation 26%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.2
P/S
P/S
Price to Sales
3.2
vs History
74
vs Industry
53
Median 3Y
3.5
Median 5Y
6.3
Industry
3.9
Forward
2.9
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
100
Median 3Y
-17.8
Median 5Y
-11
Industry
31.1
Forward
-1 848.5
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
100
Median 3Y
-44.6
Median 5Y
-17.2
Industry
23.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-11.3
Median 5Y
-9.9
Industry
27.4
More Details
2.1
P/B
P/B
Price to Book Value
2.1
vs History
69
vs Industry
52
Median 3Y
2.1
Median 5Y
4
Industry
2.5
More Details
3.4
EV/S
EV/S
Enterprise Value to Sales
3.4
vs History
74
vs Industry
47
Median 3Y
3.7
Median 5Y
6.5
Industry
3.8
Forward
3.2
More Details
8.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.2
vs History
79
vs Industry
43
Median 3Y
9.3
Median 5Y
13.9
Industry
7.9
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
4
Median 3Y
-39.1
Median 5Y
-11
Industry
17.2
Forward
90.6
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-19.9
Median 5Y
-18.2
Industry
22.7
Forward
-27.5
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
100
Median 3Y
-47
Median 5Y
-18.2
Industry
21.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-34.3
Median 5Y
-34.3
Industry
27.9
More Details
1.7
EV/IC
EV/IC
Enterprise Value to IC
1.7
vs History
71
vs Industry
54
Median 3Y
1.7
Median 5Y
3.7
Industry
2.4
More Details

Multiples Across Competitors

NEO Competitors Multiples
Neogenomics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Neogenomics Inc
NASDAQ:NEO
1.9B USD 3.2 -23.2 -98.2 -22.3
US
Thermo Fisher Scientific Inc
NYSE:TMO
221.3B USD 5.2 36.9 22.8 33.4
US
Danaher Corp
NYSE:DHR
184B USD 4.2 22.8 16.6 20.4
CH
Lonza Group AG
SIX:LONN
37.5B CHF 5.6 57.3 19.7 28.9
US
IQVIA Holdings Inc
NYSE:IQV
40.5B USD 2.7 29.9 16.3 25.2
US
Agilent Technologies Inc
NYSE:A
40.9B USD 6.1 33.1 26.4 31.8
KR
Samsung Biologics Co Ltd
KRX:207940
54.9T KRW 14.9 64 33.7 48.6
US
Mettler-Toledo International Inc
NYSE:MTD
26.9B USD 7.1 34.2 23.9 26.5
US
West Pharmaceutical Services Inc
NYSE:WST
26.6B USD 9.1 46.9 32.5 39.5
IE
ICON PLC
NASDAQ:ICLR
25.6B USD 3.1 37.4 16.9 26
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR 7.1 75.4 32.4 53.2

See Also

Summary
NEO intrinsic value, competitors valuation, and company profile.
DCF Valuation
NEO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NEO stock valuation using valuation multiples.
Wall Street Estimates
NEO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NEO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.